Single-Use That's Ready When You Are
Introducing The Mobius® MyWay Portfolio

Biopharmaceutical demand changes fast. Now, your manufacturing process can compete with that speed, and more. Our new portfolio provides shorter lead times for more rapid biomanufacturing, and it also optimizes balance of delivery speed and customization.

With three Mobius® MyWay Portfolio options, you get customizable single-use solutions that move as fast as the market. Assemblies are segmented into three categories, each offering a different level of configuration flexibility:

• Mobius® Stock offers on-demand solutions ready to ship in 24 hours.
• Mobius® Select offers an optimal balance of speed and configurability of custom assemblies from an optimized component library with an agile 6-week lead time.
• Mobius® Choice offers highly customized solutions from our expansive component library, shipped in standard lead times.

Flexible Solutions. Uncompromising Quality.
When speed and safety are critical, so is a partner with the technical expertise to ensure your manufacturing process is fully optimized and your product quality never varies. The Mobius® MyWay Portfolio is backed by decades of biopharmaceutical experience, unmatched technical support, industry leading products, and the documentation to move forward with absolute peace of mind.

We claim to now have the industry’s only comprehensive single-use solution, giving customers three different ways to create customizable assemblies. These solutions are critical to customers from contract manufacturing organizations to big pharma, whose biggest challenge is getting custom assemblies with fast, reliable lead times for quicker turnarounds and more rapid biomanufacturing. For commercial manufacturers, MilliporeSigma’s Mobius® MyWay portfolio helps minimize schedule disruptions and delays.

Whether you’re new to single-use manufacturing or looking for a partner that understands your need for predictable and reliable delivery, we can help you build a more responsive, efficient and secure biopharmaceutical production process.
Press Release Visit www.emdmillipore.com/singleuse-myway